to brain microvessels, the resultant increase in cGMP (Charbrier et al., 1987(Charbrier et al., , 1988;; Steardo and Nathanson, 19871, and the 5,000-fold greater surface area of the brain microvessels as compared to regions not protected by the BBB (Pardridge et al., 1986) suggest a physiologically
Peptide receptors in astroglia: Focus on angiotensin II and atrial natriuretic peptide
β Scribed by Dr. Colin Sumners; Wei Tang; Waltke Paulding; Mohan K. Raizada
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 828 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0894-1491
No coin nor oath required. For personal study only.
β¦ Synopsis
Astroglial cells derived from the mammalian central nervous system contain a wide variety of peptide receptors, including specific sites for angiotensin I1 (All) and atrial natriuretic peptide (ANP). The A11 receptors present in these cells are primarily of the AT, subtype. The ANP receptors present in these cells consist of a mix of ANP-A and ANP-B sites ("biological receptors") and also ANP-C sites ("clearance receptors"). Available evidence indicates that activation of AII receptors results in a stimulation of astroglial proliferation, whereas ANP has an antiproliferative effect in these cells. Intracellular pathways which may mediate these effects of A11 and ANP on cell proliferation are discussed, including the presentation of novel data on the activation of protein kinase C and of glucose uptake by AII. We also consider the possibility that the opposing actions of A11 and ANP on astroglial proliferation may represent another facet of the mutual antagonism between these two peptides, which has been observed throughout mammalian systems.
π SIMILAR VOLUMES
## Abstract Inactivation of circulating atrial natriuretic peptides (ANP) by specialized clearance (C) receptors has been characterized in mammals but has not been examined in fish. In the present study arterial blood pressure, urine flow, and urine electrolytes were measured in chronically cannula
Atrial natriuretic peptides (ANP) are potent effectors of volume homeostasis in mammals, but their effects on fluid compartments in teleost fish are unknown. In the present study, whole-body blood volume (BV: 51 Cr-red cells), and extracellular fluid volume (ECFV; 58 Co-EDTA space), and 51 Cr-red ce
The ability of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) to alter cyclic GMP levels and NaKCl cotransport in rat neocortical astrocytes was determined. At concentrations of lop9-10W6M, rat ANP99-126 (rANF), rat ANP,,,-,,, (auriculin B), and rat ANP,,,,,, (atriopeptin 111)
DuP 532, 2-propy1-4-pentafluoroethyl-l-[ [2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylJ imidazole-5-carboxylic acid, is an orally active, non-peptide angiotensin I1 (AII) receptor antagonist. DuP 532 is more potent and longer acting than losartan, another A11 receptor antagonist currently undergoing ph